Effect of zinc adminesteration to controling of blood suger in diabetic patients

A servay effect of zinc on glycemic control in diabetic patients(type 1)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT138901303596N2

Enrollment

Registered

2010-11-16

Start date

2009-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus. Insulin-dependent diabetes mellitus

Interventions

Intervention:zinc 50 mg daily..

Treatment - Drugs

Intervention:zinc 50 mg daily.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: type 1 diabetic patients; Exclusion criteria: sensitivity to zinc sulfate and HbA1C <6.5

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c level. Timepoint: At the baseline and 3 month later. Method of measurement: HPLC method.	—

Secondary

Measure	Time frame
Serum zinc. Timepoint: At the baseline and 3 month later. Method of measurement: atomic absorption spectrophotometry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Atefe Hasanzade

Jundishapour university

atefehasanzade@ajums.ac.ir+98 916 300 3304

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026